文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

维多利亚州2009-2017年乙型肝炎妇女所生婴儿围产期免疫预防的接种情况

Uptake of perinatal immunoprophylaxis for infants born to women with a record of hepatitis B in Victoria (2009-2017).
PubMed 文献 · Vaccine · 2023-02-08

该回顾性数据链接研究分析了维多利亚州2009-2017年690,052例活产中,与4196名有HBV感染记录的妇女相关的6118例婴儿。96.8%的CHB阳性母亲所生婴儿在7天内接种了出生剂量疫苗,但私立医院出生婴儿接种 odds 较低(aOR=0.17),仅2.3%记录了HBIG接种,72.4%记录存在母亲CHB状态不一致。结论认为需要协调护理和整合数据收集以支持消除HBV母婴传播。

要点

  • 96.8%的CHB阳性母亲所生婴儿在7天内接种了出生剂量疫苗
  • 私立医院出生婴儿接种出生剂量疫苗的 odds 显著低于公立医院(aOR=0.17)
  • 仅2.3%的婴儿记录了HBIG接种,72.4%记录存在母亲CHB状态不一致

核心结论

  • 需要采取协调护理和整合数据收集的方法来支持维多利亚州消除乙型肝炎母婴传播。

研究设计与样本

  • 回顾性数据链接研究,链接围产期记录、公共卫生通知和医院入院数据,识别2009-2017年间在维多利亚州分娩活产婴儿且有HBV感染记录的妇女。

主要发现

  • 在690,052例活产中,6118例出生(0.90%)与4196名有HBV感染记录的妇女链接。
  • 所有维多利亚州婴儿中89.4%(n=616,879)在7天内接种出生剂量疫苗,CHB阳性记录链接的婴儿中96.8%(n=5,925)在7天内接种。
  • 私立医院出生婴儿相比公立医院出生婴儿接种出生剂量疫苗的 odds 降低(维多利亚州人群aOR=0.67,95%CI=0.66,0.69;CHB链接记录aOR=0.17,95%CI=0.11,0.25)。
  • 在6118例与母亲CHB阳性记录链接的婴儿中,72.4%的记录存在三个数据集间母亲CHB状态记录不一致,仅2.3%的分娩记录了HBIG接种。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) remains one of the leading causes of transmission worldwide. An estimated 90 % of infants who are exposed to HBV and do not receive appropriate post exposure immunoprophylaxis will go on to develop chronic hepatitis B (CHB). In Australia, universal birth dose vaccination was adopted in 2000 and universal antenatal screening for hepatitis B was introduced in the 1990 s, however up to 10 % of women may have missed screening. There is no coordinated care or data collection that systematically reports the access to interventions to prevent mother-to-child transmission (PMTCT) for women with CHB. Therefore, the incidence rate of MTCT is unknown. METHODS: We conducted retrospective data linkage of perinatal records, public health notification and hospital admission data to identify women with a record of HBV infection who had given birth to a live infant(s) in Victoria between 2009 and 2017. We assessed uptake of birth dose vaccination and hepatitis B immunoglobulin (HBIG) and explored factors associated with administration of birth dose recorded as administered within 7 days. RESULTS: Among 690,052 live births, 6118 births (0.90 %) were linked to 4196 women with a record of HBV infection. 89.4 % of all Victorian infants (n = 616,879), and 96.8 % of infants linked to women with a positive record of CHB (n = 5,925) received birth dose within 7 days. Infants born in private hospitals had reduced odds of receiving birth dose when compared to public hospitals births (Victorian population, aOR = 0.67, 95 %CI = 0.66, 0.69; CHB linked records aOR = 0.17, 95 %CI = 0.11, 0.25). Of the 6118 infants linked to a positive maternal record of CHB, discrepant recording of maternal CHB status between the three datasets was identified in 72.4% of records and HBIG administration was recorded for only 2.3% of births. CONCLUSION: An approach that involves coordinated care and integrates data collection for women with CHB and their infants is required to support the elimination of MTCT of hepatitis B in Victoria.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Deng HM, Romero N, Allard N, et al. Uptake of perinatal immunoprophylaxis for infants born to women with a record of hepatitis B in Victoria (2009-2017). Vaccine. 2023. PMID: 36759283. doi:10.1016/j.vaccine.2023.01.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。